Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec;476(12):4363-4385.
doi: 10.1007/s11010-021-04249-4. Epub 2021 Aug 28.

Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA

Tandrima Mitra  1 , Selvakumar Elangovan  2
Affiliations
Review

Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA

Tandrima Mitra et al. Mol Cell Biochem. 2021 Dec.

Abstract

Cervical cancer (CC) is one of the leading causes of death in women due to cancer and a major concern in the developing world. Persistent human papilloma virus (HPV) infection is the major causative agent for CC. Besides HPV infection, genetic and epigenetic factors including microRNA (miRNA) also contribute to the malignant transformation. Earlier studies have revealed that miRNAs participate in cell proliferation, invasion and metastasis, angiogenesis, and chemoresistance processes by binding and inversely regulating the target oncogenes or tumor suppressor genes. Based on functions and mechanistic insights, miRNAs have been identified as cellular modulators that have an enormous role in diagnosis, prognosis, and cancer therapy. Signatures of miRNA could be used as diagnostic markers which are necessary for early diagnosis and management of CC. The therapeutic potential of miRNAs has been shown in CC; however, more comprehensive clinical trials are required for the clinical translation of miRNA-based diagnostics and therapeutics. Understanding the molecular mechanism of miRNAs and their target genes has been useful to develop miRNA-based therapeutic strategies for CC and overcome chemoresistance. In this review, we summarize the role of miRNAs in the development, progression, and metastasis of CC as well as chemoresistance. Further, we discuss the diagnostic and therapeutic potential of miRNAs to overcome chemoresistance and treatment of CC.

Keywords: Cell signaling; Cervical cancer; Chemoresistance; Metastasis; OncomiR; microRNAs.

PubMed Disclaimer

References

    1. Arbyn M, Weiderpass E, Bruni L et al (2018) Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 8:e191–e203. https://doi.org/10.1016/S2214-109X(19)30482-6 - DOI
    1. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492 - DOI - PubMed
    1. Ferlay J, Colombet M, Soerjomataram I et al (2018) Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144:1941–1953. https://doi.org/10.1002/ijc.31937 - DOI - PubMed
    1. Jiang X, Tang H, Chen T (2018) Epidemiology of gynecologic cancers in China. J Gynecol Oncol 29:e7. https://doi.org/10.3802/jgo.2018.29.e7 - DOI - PubMed
    1. Sharma G, Dua P, Agarwal SM (2014) A Comprehensive review of dysregulated miRNAs involved in cervical cancer. Curr Genomics 15:310–323. https://doi.org/10.2174/1389202915666140528003249 - DOI - PubMed - PMC

MeSH terms